A. Koczulla (Marburg, Germany), T. Mattila (Helsinki, Finland), M. Labor (Zagreb, Croatia)
Late Breaking Abstract - Plasma endocan is over-expressed in AECOPD patients: association with lung function decline and apoptosis
L. Dai (Chengdu, China), L. Lian (Chengdu, China), T. Wang (Chengdu, China), D. Xu (Chengdu, China), F. Wen (Chengdu, China)
|  |
Late Breaking Abstract - Long-term variability of blood eosinophils in COPD patients by GOLD 2017 staging, and gender bias
J. Soriano (Madrid, Spain), M. Pastor-Sanz (Madrid, Spain), E. García-Castillo (Madrid, Spain), E. Vázquez (Madrid, Spain), R. Gómez-Punter (Madrid, Spain), T. Alonso (Madrid, Spain), J. Ancochea (Madrid, Spain)
| |
The role of serum IL6 in stable COPD patients
A. Lilov (Sofia, Bulgaria), D. Marinova (Sofia, Bulgaria), Y. Slavova (Sofia, Bulgaria)
|  |
Blood Eosinophils Correlate With Severe Exacerbations in Frequent Exacerbator Phenotype of COPD
V. Jain (Fresno, United States of America), L. Jalota (Fresno, United States of America), V. Prajapati (Fresno, United States of America), D. Allison (Fresno, United States of America), R. Jain (Fresno, United States of America), J. Vempilly (Fresno, United States of America)
| |
The impact of high eosinophil count on hospitalizations in COPD patients
B. Arpinar Yigitbas (Istanbul, Turkey), E. Niksarlioglu (Istanbul, Turkey), E. Yazar (Istanbul, Turkey), L. Kilic (Istanbul, Turkey), C. Satici (Istanbul, Turkey), S. Ozden (Istanbul, Turkey)
| |
Changes in urinary biomarkers between stable state and exacerbation of COPD
A. Yousuf (Leicester, United Kingdom), G. Parekh (Bedford, United Kingdom), A. Duvoix (Bedford, United Kingdom), S. Parker (Leicester, United Kingdom), J. Finch (Leicester, United Kingdom), S. Glover (Leicester, United Kingdom), S. Rees (Cardiff, United Kingdom), V. Mistry (Leicester, United Kingdom), L. Carr (Leicester, United Kingdom), P. Davis (Bedford, United Kingdom), K. Lewis (Cardiff, United Kingdom), C. Brightling (Leicester, United Kingdom)
| |
The relationhip between serum levels of Surfactant protein D in COPD exacerbation severity and mortality
F. Günaydin (Istanbul, Turkey), N. Kalkan (Istanbul, Turkey), G. Günlüoglu (Istanbul, Turkey), E. Aktepe (Istanbul, Turkey), B. Demirkol (Istanbul, Turkey), T. Sibomana (Istanbul, Turkey), S. Altin (Istanbul, Turkey)
| |
VEGF serum levels in COPD patients without pulmonary hypertension – a case control study
A. Chis (Cluj-Napoca, Romania), O. Soritau (Cluj-Napoca, Romania), A. Catana (Cluj-Napoca, Romania), M. Pop (Cluj-Napoca, Romania)
| |
Blood MCP-1 levels are increased in chronic obstructive pulmonary disease with prevalent emphysema
A. Di Stefano (Veruno, Italy), T. Coccini (PaviaPavia, Italy), E. Roda (PaviaPavia, Italy), C. Signorini (Italy), B. Balbi (Italy), G. Brunetti (Italy), P. Ceriana (Italy)
| |
Increased serum endotoxin levels as biomarker in acute exacerbations of COPD.
E. Papatsanis (Homburg, Germany), J. Classen (Homburg, Germany), J. Demandt (Homburg, Germany), M. Patalong-Dahm (Homburg, Germany), T. Stegmaier (Homburg, Germany), C. Herr (Homburg, Germany), C. Beißwenger (Homburg, Germany), G. Vella (Homburg, Germany), F. Ritzmann (Homburg, Germany), F. Trudzinski (Homburg, Germany), T. Dinh (Homburg, Germany), P. Lepper (Homburg, Germany), S. Fähndrich (Homburg, Germany), R. Bals (Homburg, Germany)
| |
1 year RV/TLC change as a predictor of long term decline of FEV1
I. Kim (Seoul, Republic of Korea), Y. Park (Seoul, Republic of Korea), C. Rhee (Seoul, Republic of Korea), Y. Hwang (An-Yang, Republic of Korea), K. Yoo (Seoul, Republic of Korea)
| |
Exercise-induced desaturation and the functional status of patients with COPD
I. Ponomareva (Ryazan, Russian Federation), A. Kosyakov (Ryazan, Russian Federation), V. Abrosimov (Ryazan, Russian Federation)
| |
Association of serum uric acid levels and outcomes of patients with Chronic Obstructive Pulmonary Disease (COPD)
J. Galamay (Quezon City, Philippines), T. De Guia (Quezon City, Philippines), M. Limpin (Quezon City, Philippines)
| |
Association of Hypoxia-Inducible Factor (HIF)-1a and Asymmetric Dimethylarginine(ADMA) in patients with COPD and controls.
K. Upadhyay (New Delhi, India), A. Ali (New Delhi, India), B. Pattnaik (New Delhi, India), A. Agarwal (New Delhi, India), R. Guleria (New Delhi, India)
| |
Differences in expression profiles of serum microRNAs in women with mild to moderate COPD by biomass smoke exposure and tobacco smoke.
Y. Velasco (CDMX, Mexico), J. Pérez (CDMX, Mexico), M. Montaño (CDMX, Mexico), O. Pérez (CDMX, Mexico), I. Buendía (CDMX, Mexico), R. Falfán (CDMX, Mexico), V. Ruíz (CDMX, Mexico), C. Ramos (CDMX, Mexico)
| |
Expression and function of IL-20 cytokines and their receptors on the airway epithelium during Chronic Obstructive Pulmonary Disease (COPD)
O. BARADA (Lille, France), G. Kervoaze (Lille, France), C. Coraux (Reims, France), M. Polette (Reims, France), G. Deslée (Reims, France), M. Pichavant (Lille, France), P. Gosset (Lille, France)
| |
IL-18 and IL-10 in patients with occupational COPD, depending on the presence or absence of hypertension
A. Melenevych (Kharkiv, Ukraine)
| |
Relationship of HRCT-diagnosed emphysema and clinical features in COPD.
V. Kostadinova (Varna, Bulgaria), Y. Radkov (Varna, Bulgaria), T. Stoeva (Varna, Bulgaria), D. Miteva (Varna, Bulgaria)
| |
Interdisciplinary Pilot Project on Emphysema Quantification and Bronchial Wall Thickness assessment in COPD patients
B. Cuk (Sisak, Croatia), K. Krpina (Zagreb, Croatia), A. Marušic (Zagreb, Croatia), I. Markelic (Zagreb, Croatia), A. Vukic Dugac (Zagreb, Croatia), S. Popovic Grle (Zagreb, Croatia)
| |